Viewing Study NCT05929651


Ignite Creation Date: 2025-12-24 @ 11:39 PM
Ignite Modification Date: 2026-02-22 @ 4:35 AM
Study NCT ID: NCT05929651
Status: COMPLETED
Last Update Posted: 2025-09-22
First Post: 2023-06-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
Sponsor: Sanofi Pasteur, a Sanofi Company
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: MEQ00086
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators